M4K Pharma's scientific team of collaborators and partners meets online once a month to present the latest progress in the ALK2 project for DIPG. We will be meeting on the following dates from 10am-12pm EST: June 12th, 2019 July 3rd, 2019 August 7th, 2019 September 4th, 2019 October 2nd, 2019 November 6th, 2019 December 4th, [...]
Listen to a recording of the May 2019 Scientific Update Meeting Listen to M4K Pharma's Scientific Update Meeting from May 8th, 2019 where our scientists and collaborators discuss the latest progress in our Medicines4Kids project for a deadly children's brain cancer called DIPG. Everyone is invited to hear first-hand how we are [...]
Study published on new drug class targeting ACVR1 mutation for DIPG Scientists at The Institute of Cancer Research, London, along with colleagues at the Structural Genomics Consortium in Oxford, have published their findings on a new drug class that can kill brain cancer cells with mutations in the ACVR1 gene and shrink tumours in mice. Mutated versions [...]
